Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.
Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.
Last Updated： Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.
61～75 item / All 90 items
Temperature and stirring under the same conditions will streamline experiments with multiple samples.
It can stir, heat, and cool 24 reaction tubes (0.5 ml to 7 ml). A nozzle for adding is included with the water-cooled reflux head.
This is a laboratory electrochemical cell with an electrode area of 10 mm x 10 mm.
This is a laboratory electrochemical cell with an electrode area of 10 mm x 10 mm. It is designed to use 1 ml of electrolyte from the inlet to the outlet, making it ideal for testing with rare or expensive solutions.
The synthesized 4K video is automatically upscaled to 8K! Real-time synthesis is achieved.
Introducing the "Ultra Low Latency (below 20μs) Chroma Key Synthesis IP." This product enlarges 4K data to 8K and uses a proprietary algorithm from Vectorology to smooth the images, making it compatible with 8K video. The input/output latency for 8K video is below 20μs, processing four times the data volume on a single FPGA to achieve real-time synthesis. 【Features】 ■ Supports 8K/4K ■ Automatically enlarges 4K video to 8K for synthesis ■ Input to output latency for 8K video (main video) is below 20μs (less than one line time) ■ 8K synthesis output is also possible with 4K main video and 4K composite video ■ Ultra low latency synthesis (below 20μs) *For more details, please refer to the PDF document or feel free to contact us.
Developing a synthesis route for new compounds that is flexible and simple.
In the field of biotechnology research and development, the exploration of new compounds is essential. Particularly in drug discovery and the development of new materials, it is necessary to efficiently synthesize target compounds while trying out various reaction conditions. Conventional synthesis equipment may lead to decreased research efficiency due to constraints on reaction capacity, temperature range, and the complexity of operations. The 'EasyMax 102 Basic' from Mettler Toledo was developed to address these challenges. 【Usage Scenarios】 - Compound synthesis in drug discovery research - Optimization of reaction conditions in new material development - Fundamental research in the field of biotechnology 【Benefits of Implementation】 - Flexible experimental design through support for diverse reaction capacities - Wide-ranging compound synthesis through reaction control over a broad temperature range - Improved operability with one-touch control - Enhanced experimental efficiency through automatic reagent addition
![[Research Material] Global Market for Automated Peptide Synthesis Equipment](https://image.mono.ipros.com/public/product/image/1e7/2001456574/IPROS80792148019136726496.jpeg?w=280&h=280)
Global Market for Automated Peptide Synthesis Equipment: Semi-Automatic Peptide Synthesizers, Automatic Peptide Synthesizers, Academic Research Institutes, Biopharmaceutical Companies, ...
This research report (Global Automatic Peptide Synthesis Equipment Market) investigates and analyzes the current status and outlook for the global market of automatic peptide synthesis equipment over the next five years. It includes information on the overview of the global automatic peptide synthesis equipment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by key regions, and distribution channel analysis. The segments by type in the automatic peptide synthesis equipment market focus on semi-automatic peptide synthesizers and automatic peptide synthesizers, while the segments by application target school laboratories, biopharmaceutical companies, and synthesis service companies. The regional segments calculate the market size of automatic peptide synthesis equipment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the automatic peptide synthesis equipment sector, product and business overviews, and sales performance.
